Risk Stratification of Endoscopic Submucosal Dissection in Colon Tumors.
ESD
colon tumors
complication rate
success rate
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
12 Mar 2022
12 Mar 2022
Historique:
received:
01
02
2022
revised:
27
02
2022
accepted:
09
03
2022
entrez:
25
3
2022
pubmed:
26
3
2022
medline:
26
3
2022
Statut:
epublish
Résumé
Background: Endoscopic submucosal dissection (ESD) is a technique proven effective in the treatment of early neoplastic lesions in the gastrointestinal tract. However, in the case of colon lesions, many doubts remain. The purpose of our study is to stratify the success rates of the ESD procedure in the colon. Materials and Methods: A retrospective analysis of 601 patients who underwent ESD procedure for colorectal neoplasm from 2016 to 2019 in Center of Bowel Treatment, Brzeziny, Poland. Excluding 335 rectal neoplasms, we selected 266 patients with lesions located in the colon. Results: Lesions located in the left colon were characterized by the statistically higher en bloc resection and success rate, compared with the right colon—87.76% vs. 73.95% (p = 0.004) and 83.67% vs. 69.75% (p = 0.007), respectively. The success rate was significantly lower in lesions with submucosal cancer, compared to low- and high-grade dysplasia (p < 0.001). Polyps located in the right colon were characterized by a slightly higher complication rate compared to the left colon, without statistical significance—13.45% vs. 9.52% (p = 0.315). Conclusions: Our results show that colonic ESD has a high success rate, especially in the left colon, with a low risk of complications, slightly higher than in the right colon.
Identifiants
pubmed: 35329886
pii: jcm11061560
doi: 10.3390/jcm11061560
pmc: PMC8949025
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Dig Endosc. 2012 May;24 Suppl 1:105-9
pubmed: 22533763
Gastroenterology. 2018 Apr;154(5):1352-1360.e3
pubmed: 29317277
Gastrointest Endosc. 2015 Mar;81(3):583-95
pubmed: 25592748
Gastrointest Endosc. 2011 Dec;74(6):1337-46
pubmed: 22136778
World J Gastroenterol. 2014 Jul 7;20(25):8282-7
pubmed: 25009404
Eur J Gastroenterol Hepatol. 2014 Jun;26(6):607-15
pubmed: 24743502
Crit Rev Oncol Hematol. 2016 Aug;104:138-55
pubmed: 27370173
Gastrointest Endosc. 2013 Jul;78(1):8-12
pubmed: 23664162
Intern Med. 2018 Aug 1;57(15):2115-2122
pubmed: 29607956
Surg Endosc. 2012 Jun;26(6):1587-94
pubmed: 22179462
Endosc Int Open. 2019 Oct;7(10):E1195-E1196
pubmed: 31584565
Gastrointest Endosc. 2004 Aug;60(2):234-41
pubmed: 15278051
Endoscopy. 2009 Sep;41(9):758-61
pubmed: 19746316
Gastrointest Endosc. 2018 Mar;87(3):837-842
pubmed: 29133196
Surg Endosc. 2012 Aug;26(8):2220-30
pubmed: 22278105
Endosc Int Open. 2016 Oct;4(10):E1030-E1044
pubmed: 27747275
Endosc Int Open. 2018 Nov;6(11):E1340-E1348
pubmed: 30410955
Dig Endosc. 2014 Jan;26 Suppl 1:52-61
pubmed: 24191896
Surg Endosc. 2017 Sep;31(9):3690-3695
pubmed: 28180953
Dig Endosc. 2020 Jan;32(2):219-239
pubmed: 31566804
World J Gastroenterol. 2014 Nov 21;20(43):16153-8
pubmed: 25473168
Surg Endosc. 2013 Jan;27(1):31-9
pubmed: 22729707
Endosc Int Open. 2019 Feb;7(2):E239-E259
pubmed: 30705959
Dig Dis. 2019;37(1):53-62
pubmed: 30227392
Gastrointest Endosc. 2010 Dec;72(6):1217-25
pubmed: 21030017
Endosc Int Open. 2016 Aug;4(8):E895-900
pubmed: 27540580
Int J Colorectal Dis. 2017 Dec;32(12):1711-1717
pubmed: 28884225
United European Gastroenterol J. 2016 Feb;4(1):18-29
pubmed: 26966519